Related Experiment Video

Updated: Apr 2, 2026

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence
13:59

A Quantitative Measurement of Reactive Oxygen Species and Senescence-associated Secretory Phenotype in Normal Human Fibroblasts During Oncogene-induced Senescence

Published on: August 12, 2018

8.7K

ARF: connecting senescence and innate immunity for clearance

Alper Y Kearney1,2, Benedict Anchang3, Sylvia Plevritis3

  • 1Division of Oncology, Departments of Medicine and Pathology, Molecular Imaging Program, Stanford University, Stanford, CA 94305, USA.

Aging
|September 29, 2015
PubMed

Insights

ARF and p53 are crucial for tumor regression after MYC inactivation. ARF independently regulates genes for senescence and immune response, impacting therapeutic resistance to oncogene inactivation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • MYC is a potent oncogene frequently activated in various cancers.
  • Targeted inactivation of MYC is a promising therapeutic strategy.
  • Understanding resistance mechanisms to MYC inactivation is critical.

Purpose of the Study:

  • To elucidate the distinct roles of ARF and p53 in tumor regression following MYC inactivation.
  • To investigate the p53-independent functions of ARF in this process.
  • To explore the implications for therapeutic resistance.

Main Methods:

  • Utilized preclinical cancer models with MYC inactivation.
  • Assessed tumor regression dynamics.
  • Analyzed gene expression changes related to cellular senescence and immune activation.
  • Investigated the involvement of ARF and p53 pathways.

Main Results:

  • ARF and p53 are essential for tumor regression upon MYC inactivation.
  • ARF acts through a p53-independent mechanism.
  • ARF regulates genes critical for inducing cellular senescence.
  • ARF is required for the recruitment of innate immune activation.

Conclusions:

  • ARF and p53 play distinct, essential roles in mediating tumor regression after MYC inactivation.
  • ARF's p53-independent regulation of senescence and immune genes is a key finding.
  • These mechanisms may inform strategies to overcome therapeutic resistance to MYC-targeted therapies.
Keywords:
Myc inactivationinnate immunityp19arfsenescence

More Related Videos

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells08:56

Simultaneous Imaging and Flow-Cytometry-based Detection of Multiple Fluorescent Senescence Markers in Therapy-Induced Senescent Cancer Cells

Published on: July 12, 2022

3.7K
Induction and Validation of Cellular Senescence in Primary Human Cells08:18

Induction and Validation of Cellular Senescence in Primary Human Cells

Published on: June 20, 2018

18.3K

Related Concept Videos

Introduction to Innate and Adaptive Immunity01:21

Introduction to Innate and Adaptive Immunity

The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
12.5K
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
10.5K
Cells of the Adaptive Immune Response01:23

Cells of the Adaptive Immune Response

The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
10.1K
What is the Immune System?01:38

What is the Immune System?

Overview
147.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
86.4K